• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Allergan Inc. (AGN)

    -NYSE
    212.18 Up 4.15(1.99%) 4:06PM EST
    |After Hours : 212.18 0.00 (0.00%) 6:47PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 6,300,400   5,646,600   5,216,000  
    Cost of Revenue795,800  751,200  718,000  
    Gross Profit 5,504,600   4,895,400   4,498,000  
    Operating Expenses
    Research Development1,042,300  977,300  871,500  
    Selling General and Administrative2,519,400  2,193,100  2,158,300  
    Non Recurring16,900  23,800  7,500  
    Others116,700  90,200  86,100  
    Total Operating Expenses3,695,300  3,284,400  3,123,400  
    Operating Income or Loss 1,809,300   1,611,000   1,374,600  
    Income from Continuing Operations
    Total Other Income/Expenses Net(3,500)(16,400)6,400  
    Earnings Before Interest And Taxes1,805,800  1,594,600  1,381,000  
    Interest Expense75,000  63,600  71,800  
    Income Before Tax1,730,800  1,531,000  1,309,200  
    Income Tax Expense458,300  430,300  359,600  
    Minority Interest(3,600)(3,700)(3,600)
    Net Income From Continuing Ops1,272,500  1,100,700  949,600  
    Non-recurring Events
    Discontinued Operations(283,800)1,800  (11,500)
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 985,100   1,098,800   934,500  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 985,100   1,098,800   934,500  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.